medicexum
TransactionsConfidential mandates

Confidential buy-side & sell-side mandates in UK medicinal cannabis.

Medicexum runs a discreet introductions process for founders, owners and investors transacting in UK medicinal cannabis, CBD and adjacent regulated sectors. No mandate is named publicly. Nothing identifying is released without signed NDA, non-circumvent and introducer-fee agreements in place.

Register as buyer / investorDiscuss a sale mandate
01

Identity withheld until NCNDA + IFA signed

No company names, financials or licences are shared until a mutual NDA, non-circumvent and introducer fee agreement are executed by all parties.

02

Qualification-gated access

Buyers complete a regulated-status and source-of-funds declaration before any blind teaser is released. Sellers approve every party a teaser is shown to.

03

Staged disclosure

Blind teaser → CIM in a permissioned, watermarked data room → management meeting under LOI exclusivity. Each step requires written interest.

Process

How a Medicexum introduction runs.

  1. Step 1 Qualification (regulated status, jurisdiction, ticket size, source of funds).
  2. Step 2 Mutual NCNDA + Introducer Fee Agreement executed via DocuSign.
  3. Step 3 Blind 1-page teaser shared (sector, region, revenue band, licences — no name).
  4. Step 4 CIM and data room access in a permissioned, watermarked VDR after written interest.
  5. Step 5 Management meetings under LOI exclusivity.
Speak in confidence